Akari Therapeutics, Statistics
Total Valuation
AKTX has a market cap or net worth of $18.73 million. The enterprise value is $11.73 million.
| Market Cap | 18.73M |
| Enterprise Value | 11.73M |
Important Dates
The last earnings date was Thursday, August 13, 2026, after market close.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AKTX has 1.95 million shares outstanding. The number of shares has increased by 128.91% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.95M |
| Shares Change (YoY) | +128.91% |
| Shares Change (QoQ) | +20.68% |
| Owned by Insiders (%) | 28.96% |
| Owned by Institutions (%) | 212.55% |
| Float | 1.27M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.85 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.60, with a Debt / Equity ratio of 0.04.
| Current Ratio | 0.60 |
| Quick Ratio | 0.55 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -13.89 |
Financial Efficiency
Return on equity (ROE) is -140.09% and return on invested capital (ROIC) is -36.82%.
| Return on Equity (ROE) | -140.09% |
| Return on Assets (ROA) | -19.10% |
| Return on Invested Capital (ROIC) | -36.82% |
| Return on Capital Employed (ROCE) | -55.41% |
| Weighted Average Cost of Capital (WACC) | 15.70% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$5.16M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.86M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -70.76% in the last 52 weeks. The beta is 1.39, so AKTX's price volatility has been higher than the market average.
| Beta (5Y) | 1.39 |
| 52-Week Price Change | -70.76% |
| 50-Day Moving Average | 9.60 |
| 200-Day Moving Average | 10.17 |
| Relative Strength Index (RSI) | 59.09 |
| Average Volume (20 Days) | 56,328 |
Short Selling Information
The latest short interest is 37,660, so 3.37% of the outstanding shares have been sold short.
| Short Interest | 37,660 |
| Short Previous Month | 27,299 |
| Short % of Shares Out | 3.37% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.95 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -13.68M |
| Pretax Income | -32.82M |
| Net Income | -30.96M |
| EBITDA | n/a |
| EBIT | -13.68M |
| Earnings Per Share (EPS) | -$23.94 |
Balance Sheet
The company has $7.69 million in cash and $693,000 in debt, with a net cash position of $7.00 million or $3.60 per share.
| Cash & Cash Equivalents | 7.69M |
| Total Debt | 693,000 |
| Net Cash | 7.00M |
| Net Cash Per Share | $3.60 |
| Equity (Book Value) | 18.60M |
| Book Value Per Share | 10.62 |
| Working Capital | -5.61M |
Cash Flow
| Operating Cash Flow | -10.76M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | 1.44M |
| Free Cash Flow | -10.76M |
| FCF Per Share | -$5.53 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AKTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -128.91% |
| Shareholder Yield | -128.91% |
| Earnings Yield | -176.49% |
| FCF Yield | -61.33% |
Analyst Forecast
The average price target for AKTX is $28.50, which is 196.26% higher than the current price. The consensus rating is "Buy".
| Price Target | $28.50 |
| Price Target Difference | 196.26% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 31, 2026. It was a reverse split with a ratio of 1:40.
| Last Split Date | Mar 31, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:40 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |